Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Condition(s):NeuroblastomaLast Updated:March 7, 2022Completed
Hide Studies Not Open or Pending
Condition(s):NeuroblastomaLast Updated:March 7, 2022Completed
Condition(s):B-cell Non Hodgkin’s LymphomaLast Updated:August 1, 2014Completed
Condition(s):Acute Graft-versus-host DiseaseLast Updated:September 16, 2014Unknown status
Condition(s):Alzheimer DiseaseLast Updated:October 4, 2023Not yet recruiting
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 23, 2020Terminated
Condition(s):Migraine; Head PainLast Updated:February 14, 2024Recruiting
Condition(s):Chronic Hepatitis CLast Updated:October 25, 2011Unknown status
Condition(s):Acute Myeloblastic Leukemia; Acute Lymphoblastic Leukemia; Juvenile Myelomonocytic LeukemiaLast Updated:June 25, 2021Completed
Condition(s):Advanced Solid TumorsLast Updated:April 10, 2023Completed
Condition(s):Solid Tumor, AdultLast Updated:July 30, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.